175 related articles for article (PubMed ID: 20353772)
1. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
Bari M; Rapino C; Mozetic P; Maccarrone M
Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
4. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system: a new entry in remote cell death mechanisms.
Viscomi MT; Oddi S; Latini L; Bisicchia E; Maccarrone M; Molinari M
Exp Neurol; 2010 Jul; 224(1):56-65. PubMed ID: 20353775
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
Witting A; Chen L; Cudaback E; Straiker A; Walter L; Rickman B; Möller T; Brosnan C; Stella N
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6362-7. PubMed ID: 16571660
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system and neurogenesis in health and disease.
Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
Neuroscientist; 2007 Apr; 13(2):109-14. PubMed ID: 17404371
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
Rice AS; Farquhar-Smith WP; Nagy I
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors: where they are and what they do.
Mackie K
J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system in neuropathological states.
Orgado JM; Fernández-Ruiz J; Romero J
Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system and amyloid-related diseases.
Ruiz-Valdepeñas L; Benito C; Tolón RM; Martínez Orgado JA; Romero J
Exp Neurol; 2010 Jul; 224(1):66-73. PubMed ID: 20353781
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the endocannabinoid system in obesity.
Engeli S
J Neuroendocrinol; 2008 May; 20 Suppl 1():110-5. PubMed ID: 18426509
[TBL] [Abstract][Full Text] [Related]
18. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system as a target for the treatment of neuronal damage.
Fernández-Ruiz J; García C; Sagredo O; Gómez-Ruiz M; de Lago E
Expert Opin Ther Targets; 2010 Apr; 14(4):387-404. PubMed ID: 20230193
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
Jonsson KO; Holt S; Fowler CJ
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]